CAMBRIDGE, Mass.– Iterative Health and One GI® have entered into a strategic partnership to expand clinical research across One GI’s network of community practices. The agreement will make research a standard part of care and broaden patient access to clinical trials.
One GI operates 34 clinics in six states. Thirteen of those already run research programs and will now join Iterative Health’s global site network. The collaboration links One GI’s existing research operations with Iterative Health’s trial management model, designed to deliver studies quickly and at scale.
“Advancing medicine through research is central to our mission of improving health outcomes for our patients and communities,” said Christa Newton, CEO of One GI. “Our partnership with Iterative Health strengthens our established research ancillary through shared expertise and proven support, ensuring our physicians can expand patients’ access to leading-edge treatments.”
“Iterative Health has been a trusted partner to our site for several years, and I’ve seen firsthand the depth of their support and expertise,” said Dr. Ziad Younes, a principal investigator at One GI. “By enhancing our research operations, they’ve allowed my team to focus fully on what matters most—caring for our patients. This new partnership ensures even more One GI physicians can offer cutting-edge therapies close to home, without patients ever needing to leave the communities and providers they know and trust.”
“We are privileged that One GI has chosen to partner with Iterative Health in our journey to create the highest quality and fastest network of gastroenterology research sites,” said Jonathan Ng, CEO of Iterative Health. “In partnership with One GI research, we have consistently demonstrated industry-leading results through our unique operating model over the past two years. We look forward to furthering clinical trial innovation together in the years ahead.”
